Variation in Fluid and Vasopressor Use in Shock With and Without Physiologic Assessment: A Multicenter Observational Study.
APACHE
Adult
Aged
Aged, 80 and over
Blood Pressure
Central Venous Pressure
Dose-Response Relationship, Drug
Female
Fluid Therapy
/ methods
Hospital Mortality
/ trends
Humans
Intensive Care Units
/ statistics & numerical data
Male
Middle Aged
Organ Dysfunction Scores
Prospective Studies
Shock
/ diagnosis
Vasoconstrictor Agents
/ administration & dosage
Journal
Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
4
7
2020
medline:
26
5
2021
entrez:
4
7
2020
Statut:
ppublish
Résumé
To characterize the association between the use of physiologic assessment (central venous pressure, pulmonary artery occlusion pressure, stroke volume variation, pulse pressure variation, passive leg raise test, and critical care ultrasound) with fluid and vasopressor administration 24 hours after shock onset and with in-hospital mortality. Multicenter prospective cohort study between September 2017 and February 2018. Thirty-four hospitals in the United States and Jordan. Consecutive adult patients requiring admission to the ICU with systolic blood pressure less than or equal to 90 mm Hg, mean arterial blood pressure less than or equal to 65 mm Hg, or need for vasopressor. None. Of 1,639 patients enrolled, 39% had physiologic assessments. Use of physiologic assessment was not associated with cumulative fluid administered within 24 hours of shock onset, after accounting for baseline characteristics, etiology and location of shock, ICU types, Acute Physiology and Chronic Health Evaluation III, and hospital (beta coefficient, 0.04; 95% CI, -0.07 to 0.15). In multivariate analysis, the use of physiologic assessment was associated with a higher likelihood of vasopressor use (adjusted odds ratio, 1.98; 95% CI, 1.45-2.71) and higher 24-hour cumulative vasopressor dosing as norepinephrine equivalent (beta coefficient, 0.37; 95% CI, 0.19-0.55). The use of vasopressor was associated with increased odds of in-hospital mortality (adjusted odds ratio, 1.88; 95% CI, 1.27-2.78). In-hospital mortality was not associated with the use of physiologic assessment (adjusted odds ratio, 0.86; 95% CI, 0.63-1.18). The use of physiologic assessment in the 24 hours after shock onset is associated with increased use of vasopressor but not with fluid administration.
Identifiants
pubmed: 32618697
doi: 10.1097/CCM.0000000000004429
pii: 00003246-202010000-00005
pmc: PMC10072792
mid: NIHMS1849919
doi:
Substances chimiques
Vasoconstrictor Agents
0
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1436-1444Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL130648
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR000129
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002369
Pays : United States
Investigateurs
Tina McCurry
(T)
Jeremy R DeGrado
(JR)
Kevin M Dube
(KM)
Kenneth E Lupi
(KE)
Andrei Hastings
(A)
Omar Mehkri
(O)
Raquel R Bartz
(RR)
Angela L Pollak
(AL)
Sarah Kendall Smith
(SK)
Marguerite Stewart
(M)
Leona Wells
(L)
Jamie Kerestes
(J)
Kayla Kotch
(K)
Sarah Miller
(S)
Brent Armbruster
(B)
Valerie Aston
(V)
Katie Brown
(K)
Mardee Merrill
(M)
Nadeen Anabtawi
(N)
Kerri L Federico
(KL)
Peter-John Trapp
(PJ)
Joseph C Farmer
(JC)
Pablo Moreno Franco
(PM)
Shurong Gong
(S)
Rahul Kashyap
(R)
Sidhant Singh
(S)
Reagan D Collins
(RD)
Natasha Lopez
(N)
Kristy Phillips
(K)
Jorge Ataucuri-Vargas
(J)
Vladyslav Dieiev
(V)
Ashley Kang
(A)
Ann Wang
(A)
Neha N Goel
(NN)
Oscar Mitchell
(O)
Jordan DeWitt
(J)
Abby Tyson
(A)
Parshwan Lahiji
(P)
Dubier Matos
(D)
Ebaad Haq
(E)
Katie Dalton
(K)
Drayton Hammond
(D)
Gourang Patel
(G)
Valentina Amaral
(V)
Jasmine Aulakh
(J)
Nauman Farooq
(N)
Kerra Cissne
(K)
Jose Camarena
(J)
Kristen Deupree
(K)
Alexia Demitsas
(A)
Karen Lutrick
(K)
Nora Elson
(N)
Dina Gomaa
(D)
John Shinn
(J)
Anthony Spuzzillo
(A)
Devin Wakefield
(D)
Mehrnaz Pajoumand
(M)
Sharon Wilson
(S)
Siu Yan Amy Yeung
(SYA)
Tina Chen
(T)
Sinan Hanna
(S)
Lauren Sinko
(L)
Kassidy Malone
(K)
Deamber Piel
(D)
Chloe Skidmore
(C)
Ji Yeon Seo
(JY)
Matt Flynn
(M)
Nicole M Acquisto
(NM)
Kathryn Connor
(K)
Samantha Delibert
(S)
Christine Groth
(C)
Jeff Huntress
(J)
Gregory Kelly
(G)
Therese Makhoul
(T)
Hannah Mierzwa
(H)
Stephen Rappaport
(S)
Daisy Rios
(D)
Bethany Crouse
(B)
Abdalla A Ammar
(AA)
Shamsuddin Akhtar
(S)
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Intensive Care Med. 2015 Feb;41(2):248-56
pubmed: 25447804
Intensive Care Med. 2015 Sep;41(9):1529-37
pubmed: 26162676
Ann Intern Med. 2018 Apr 17;168(8):558-568
pubmed: 29459977
Ann Intensive Care. 2016 Dec;6(1):49
pubmed: 27246463
Crit Care. 2015 Jan 08;19:5
pubmed: 25572383
Crit Care Med. 2015 Jan;43(1):3-12
pubmed: 25275252
N Engl J Med. 2008 Feb 28;358(9):877-87
pubmed: 18305265
Crit Care Med. 2016 Oct;44(10):1923-6
pubmed: 27465720
Crit Care Med. 2017 Sep;45(9):1538-1545
pubmed: 28817481
Crit Care Med. 2017 Mar;45(3):486-552
pubmed: 28098591
Anesth Analg. 2017 Mar;124(3):846-848
pubmed: 27749338
Blood. 2014 Jul 10;124(2):188-95
pubmed: 24876563
Ann Intensive Care. 2016 Dec;6(1):111
pubmed: 27858374
JAMA. 2010 Feb 24;303(8):739-46
pubmed: 20179283
Ann Emerg Med. 2016 Mar;67(3):367-378.e3
pubmed: 26475246
Crit Care Med. 2009 Sep;37(9):2642-7
pubmed: 19602972
Crit Care. 2007;11(1):R24
pubmed: 17313691
Kidney Dis (Basel). 2016 Jun;2(2):64-71
pubmed: 27536694
N Engl J Med. 2013 Oct 31;369(18):1726-34
pubmed: 24171518
Burns. 2004 Dec;30(8):798-807
pubmed: 15555792
N Engl J Med. 2010 Mar 4;362(9):779-89
pubmed: 20200382
J Clin Monit Comput. 2018 Jun;32(3):403-414
pubmed: 28593456
Adv Health Sci Educ Theory Pract. 2018 Oct;23(4):749-765
pubmed: 29691699
JAMA. 2016 Sep 27;316(12):1298-309
pubmed: 27673307
Shock. 2015 Jan;43(1):68-73
pubmed: 25247784